Deals
Smith & Nephew Drops on Report of Deal Talks With NuVasive
- NuVasive racing to introduce robotic spinal surgery product
- Smith & Nephew has signaled it’s searching for bigger deals
Photographer: shapecharge/E+ via Getty Images
This article is for subscribers only.
Smith & Nephew Plc dropped on a report that the medical-device manufacturer is in talks with NuVasive Inc. about a deal worth more than $3 billion to gain spinal surgery products.
The stock fell as much as 5.5 percent in London Monday. NuVasive share rose 11 percent to $54.85 at 9:57 a.m. in New York, after a report Friday in the Financial Times on the possible interest from the U.K. company.